Summit Therapeutics
(NASDAQ) SMMT
Summit Therapeutics Financials at a Glance
Market Cap
$14.07B
Revenue (TTM)
$0.00
Net Income (TTM)
$1.05B
EPS (TTM)
$-1.60
P/E Ratio
-11.31
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$16.91
Volume
2,673,146.368
Open
$17.78
Price
$16.91
Volume
2,673,146.368
Open
$17.78
Previous Close
$16.87
Daily Range
$16.84 - $17.95
52-Week Range
$13.83 - $30.98
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$16.91
Volume
2,673,146.368
Open
$17.78
Previous Close
$16.87
Daily Range
$16.84 - $17.95
52-Week Range
$13.83 - $30.98
SMMT News
SMMT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Summit Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
265
CEO
Robert William Duggan; Mahkam Zanganeh, DDS, MBA
Website
www.smmttx.comHeadquarters
Cambridge, MA 02142, US
SMMT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-271%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-8.84%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.07B
Shares Outstanding
775.37M
Volume
2.67M
Avg. Volume
3.33M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.09B
EBITDA
$1.08B
Operating Cash Flow
$239.67M
Capital Expenditure
$487.60K
Free Cash Flow
$240.15M
Cash & ST Invst.
$529.49M
Total Debt
$15.50M
Summit Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$14.07B
N/A
Market Cap/Employee
$88.46M
N/A
Employees
159
N/A
Net Income
$189.42M
-289.0%
EBITDA
$195.17M
-277.3%
Quarterly Fundamentals
Net Cash
$438.86M
+59.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$12.79M
+467.8%
Short Term Debt
$2.41M
-12.1%
Return on Assets
-2.14%
N/A
Return on Invested Capital
-2.50%
N/A
Free Cash Flow
$92.93M
-94.8%
Operating Cash Flow
$92.74M
-95.7%